News Releases

News Releases

Prometheus Biosciences Announces Upsized Pricing of Initial Public Offering

Mar 11, 2021
SAN DIEGO, March 11, 2021 / PRNewswire / -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory
Displaying 11 - 20 of 26